scholarly journals Nucleotide sequence comparison between heat-labile toxin B-subunit cistrons from Escherichia coli of human and porcine origin.

1985 ◽  
Vol 48 (1) ◽  
pp. 73-77 ◽  
Author(s):  
J Leong ◽  
A C Vinal ◽  
W S Dallas
2009 ◽  
Vol 44 (1) ◽  
pp. 14-21 ◽  
Author(s):  
Tae-Geum Kim ◽  
Bang-Geul Kim ◽  
Mi-Young Kim ◽  
Jae-Kwon Choi ◽  
Eun-Sun Jung ◽  
...  

2012 ◽  
Vol 58 (6) ◽  
pp. 802-810 ◽  
Author(s):  
Cuiming Zhu ◽  
Shiping Wang ◽  
Shihai Hu ◽  
Minjun Yu ◽  
Yanhua Zeng ◽  
...  

In the present study, we investigated the immunomodulatory responses of a DNA vaccine constructed by fusing Mycoplasma pneumoniae P1 protein carboxy terminal region (P1C) with the Escherichia coli heat-labile toxin B subunit (LTB). BALB/c mice were immunized by intranasal inoculation with control DNAs, the P1C DNA vaccine or the LTB–P1C fusion DNA vaccine. Levels of the anti-M. pneumoniae antibodies and levels of interferon-γ and IL-4 in mice were increased significantly upon inoculation of the LTB–P1C fusion DNA vaccine when compared with the inoculation with P1C DNA vaccine. The LTB–P1C fusion DNA vaccine efficiently enhanced the M. pneumoniae-specific IgA and IgG levels. The IgG2a/IgG1 ratio was significantly higher in bronchoalveolar lavages fluid and sera from mice fusion with LTB and P1C than mice receiving P1C alone. When the mice were challenged intranasally with 107 CFU M. pneumoniae strain (M129), the LTB–P1C fusion DNA vaccine conferred significantly better protection than P1C DNA vaccine (P < 0.05), as suggested by the results, such as less inflammation, lower histopathological score values, lower detectable number of M. pneumoniae strain, and lower mortality of challenging from 5 × 108 CFU M. pneumoniae. These results indicated that the LTB–P1C fusion DNA vaccine efficiently improved protective efficacy against M. pneumoniae infection and effectively attenuated development of M. pneumoniae in mice.


2007 ◽  
Vol 115 (3) ◽  
pp. 354-360 ◽  
Author(s):  
April J. Beyer ◽  
Kan Wang ◽  
Amber N. Umble ◽  
Jeffrey D. Wolt ◽  
Joan E. Cunnick

2014 ◽  
Vol 62 (3) ◽  
pp. 293-303
Author(s):  
In-Gyeong Oh ◽  
Chetan Jawale ◽  
John Lee

This study aimed to investigate the adjuvant effect of recombinant attenuatedSalmonellaexpressing cholera toxin B subunit (CTB) andEscherichia coliheat-labile enterotoxin B subunit (LTB) for the P-fimbriae subunit-based vaccine of avian pathogenicE. coli(APEC) in a murine model. The PapA-specific sIgA and IgG responses were significantly enhanced after immunisation with theSalmonella-PapA vaccine in the presence of CTB or LTB. The group immunised with theSalmonella-LTB strain promoted Th1-type immunity, whereas that immunised with theSalmonella-CTB strain produced Th2-type immunity. We concluded that bothSalmonella-CTB and -LTB strains can enhance the immune response to PapA, and that the LTB strain may be a more effective adjuvant for APEC vaccination, which requires higher Th1-type immunity for protection. Thus, our findings provide evidence that immunisation with an adjuvant, LTB, is one of the strategies of developing effective vaccines against P-fimbriated APEC.


1985 ◽  
Vol 48 (3) ◽  
pp. 735-740 ◽  
Author(s):  
R A Houghten ◽  
R F Engert ◽  
J M Ostresh ◽  
S R Hoffman ◽  
F A Klipstein

1996 ◽  
Vol 64 (4) ◽  
pp. 1290-1298 ◽  
Author(s):  
I Takahashi ◽  
H Kiyono ◽  
R J Jackson ◽  
K Fujihashi ◽  
H F Staats ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document